Antibodies directed to angiopoietin-2 and uses thereof

Details for Australian Patent Application No. 2005319382 (hide)

Owner AstraZeneca AB

Inventors Yang, Xiao-Dong; Green, Larry L.; Emery, Stephen Charles; Zhou, Qing; Keyt, Bruce A.; Blakey, David C.

Agent Allens Arthur Robinson

Pub. Number AU-B-2005319382

PCT Pub. Number WO2006/068953

Priority 60/638,354 21.12.04 US; 60/711,289 25.08.05 US

Filing date 19 December 2005

Wipo publication date 29 June 2006

Acceptance publication date 7 April 2011

International Classifications

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

Event Publications

5 July 2007 PCT application entered the National Phase

  PCT publication WO2006/068953 Priority application(s): WO2006/068953

7 April 2011 Application Accepted

  Published as AU-B-2005319382

4 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005319388-Electrokinetic device employing a nonNewtonian liquid

2005319381-Heat resistant plastic lamp components and methods of forming